DERIVO® 2heal® Embolisation Device

Braided, self-expanding nitinol Flow Diverter with HEAL Technology

Picture DERIVO®  2heal® Embolisation Device

  • HEAL Technology (next generation antithrombogenic coating). Learn more >
  • Perfect match of number of wires and wire thickness for excellent opening behaviour, perfect wall position and best flow diversion effect = ALMOST TAILOR-MADE
  • Reliable distal opening behaviour due to closed ends
  • Excellent visibility due to nitinol composite wires with platinum core
  • Broad portfolio with lengths up to 50 mm, CE mark approved for the treatment of vessel diameters from 1.5 - 8.0 mm
  • Compatible with 0.0165’’ - 0.039’’ ID (micro)catheters
  • Case-specific 3D sizing support

The DERIVO® 2heal® Embolisation Device is currently in Limited Market Release. Please contact your Acandis® representative for product availability.


Clinical Experience

Case DERIVO®  2heal® Embolisation Device

Images are courtesy of Dr. Andreas Simgen, Clinic for Neuroradiology Westpfalz-Klinikum GmbH Kaiserslautern, Germany


Note: Magnetic Resonance Imaging (MRI) Information
Non-clinical tests have shown that the Acandis implant is suitable for MR-examination. After implantation, patients can be safely scanned with a static magnetic field of 3 Tesla. The MR imaging quality may be affected if the implant is located in the area of interest. Optimisation of the imaging parameters is recommended. For further information on MRI compatibility please consult the instructions for use of the respective product.

Please consult the Instructions for Use for all indications, contraindications, warnings, cautions as well as possible adverse effects. Acandis® products are to be used exclusively by trained medical professionals. Orders are taken only in regions where the product is approved. Please contact an Acandis® representative for product availability.